Basil Al Khatib, MD
Interventional Cardiology · Phoenix, AZNPI 1083977599
Payments from drug & device makers
Across 341 payments — averaging $96.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$13K
- Medtronic$6K
- Boston Scientific$3K
- Abbott$2K
- Abiomed$2K
- Medical Device Business Services, Inc.$868
- plus $6K from 33 others
Across 1 payment — averaging $6428.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$6K
What the payments were for
- Consulting fees$5,16016%
- Travel & lodging$10,97933%
- Food & beverage$16,51750%
- Education$1911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 62 | $12,890 |
| Medtronic(2 entities) | 66 | $6,027 |
| Boston Scientific | 42 | $3,467 |
| Abbott | 33 | $2,181 |
| Abiomed | 31 | $1,557 |
| Medical Device Business Services, Inc. | 4 | $868 |
| Inari Medical, Inc. | 4 | $697 |
| Cardiva Medical, Inc. | 11 | $533 |
| Penumbra, Inc. | 3 | $439 |
| Biosense Webster, Inc. | 8 | $412 |
| Shockwave Medical, Inc | 2 | $316 |
| Philips North America LLC | 5 | $303 |
| E.r. Squibb & Sons, L.L.C. | 17 | $294 |
| Angiodynamics, Inc. | 2 | $274 |
| Amgen | 5 | $194 |
| Kestra Medical Technology Services, Inc. | 3 | $192 |
| Stryker | 1 | $171 |
| Impulse Dynamics (USA) Inc. | 2 | $169 |
| Johnson & Johnson | 11 | $169 |
| Viz.ai, Inc. | 1 | $164 |
| Cvrx, Inc. | 2 | $163 |
| Livanova USA, Inc. | 1 | $156 |
| Inspire Medical Systems, Inc. | 1 | $150 |
| ZOLL Respicardia, Inc. | 1 | $142 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $139 |
| Actelion Pharmaceuticals US, Inc. | 2 | $126 |
| Biotronik Inc. | 1 | $123 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $113 |
| Acist Medical Systems, Inc. | 2 | $100 |
| Astellas Pharma US Inc | 1 | $99 |
| Atricure, Inc. | 1 | $47 |
| Merck | 2 | $35 |
| Novartis | 1 | $31 |
| AstraZeneca | 2 | $27 |
| Medline Industries LP | 1 | $18 |
| Akcea Therapeutics, Inc. | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Pfizer | 1 | $15 |
| Gilead | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$7,511
- PASCAL$1,760
- CoreValve Evolut$1,686
- COREVALVE EVOLUT R$1,500
- EVOQUE$1,379
- MitraClip$1,292
- Impella$911
- Carto 3$868
- FLOWTRIEVER CATHETER, S$697
- CT THROMBECTOMY SYSTEM KIT$697
- Micra$529
- Indigo System$439
- AVVIGO Guidance System$380
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$316
- OPTIMIZER$295
- 3F$226
- SAPIEN 3 Ultra RESILIA$217
- Carpentier-Edwards Physio II Annuloplasty Ring$202
- GENERAL - THERAPIES$181
- RESOLUTE ONYX$180
How this compares
$32,847 in reported general payments places this provider in the 70th percentile of 223 interventional cardiology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 202 | $222,908 |
| CamzyosMavacamten | 18 | $130,540 |
| XareltoRivaroxaban | 37 | $48,010 |
| FarxigaDapagliflozin Propanediol | 33 | $43,496 |
| Repatha SureclickEvolocumab | 19 | $26,655 |
| EntrestoSacubitril/Valsartan | 18 | $26,018 |
| Praluent PenAlirocumab | 19 | $16,522 |
| OzempicSemaglutide | 15 | $13,863 |
| BrilintaTicagrelor | 12 | $11,753 |
| Metoprolol Succinate | 220 | $3,575 |
| LivaloPitavastatin Calcium | 11 | $3,460 |
| Atorvastatin Calcium | 270 | $2,537 |
| ClopidogrelClopidogrel Bisulfate | 174 | $1,916 |
| Valsartan | 19 | $1,796 |
| Enoxaparin Sodium | 11 | $1,492 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $15 | $222,908202 claims |
| E.r. Squibb & Sons, L.L.C.Camzyos | $294 | $130,54018 claims |
| AstraZenecaFarxiga, Brilinta | $27 | $55,24945 claims |
| Johnson & JohnsonXarelto | $169 | $48,01037 claims |
| NovartisEntresto | $31 | $26,01818 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 223 interventional cardiology providers in Arizona.
Other interventional cardiology in Phoenix
- Paul SorajjaPhoenix$8.8M
- Timothy ByrnePhoenix$2.1M
- Mohamad LazkaniPhoenix$1.1M
- Parminder SinghPhoenix$854K
- Akil LoliPhoenix$506K
- Haidar YassinPhoenix$457K
- Michael WhitePhoenix$417K
- Nezar FallujiPhoenix$348K
- Floyd FortuinPhoenix$263K
- Nishant GuptaPhoenix$196K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.